The N6-methyladenosine demethylase ALKBH5 regulates the hypoxic HBV transcriptome

被引:5
|
作者
Tsukuda, Senko [1 ]
Harris, James M. [1 ]
Magri, Andrea [1 ]
Balfe, Peter [1 ]
Siddiqui, Aleem [2 ]
Wing, Peter A. C. [3 ]
Mckeating, Jane A. [1 ,2 ]
机构
[1] Univ Oxford, Nuffield Dept Med, Oxford, England
[2] Univ Calif Irvine, Dept Med, Irvine, CA 92697 USA
[3] Univ Oxford, Oxford Inst, Chinese Acad Med Sci, Oxford, England
基金
英国惠康基金;
关键词
MESSENGER-RNA; VIRUS-REPLICATION; VIRAL REPLICATION; M(6)A; EXPRESSION; N-6-METHYLADENOSINE; REVEALS; LIVER; TRANSLATION; METABOLISM;
D O I
10.1371/journal.ppat.1011917
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Chronic hepatitis B is a global health problem and current treatments only suppress hepatitis B virus (HBV) infection, highlighting the need for new curative treatments. Oxygen levels influence HBV replication and we previously reported that hypoxia inducible factors (HIFs) activate the basal core promoter (BCP). Here we show that the hypoxic-dependent increase in BCP-derived transcripts is dependent on N6-methyladenosine (m6A) modifications in the 5' stem loop that regulate RNA half-life. Application of a probe-enriched long-read sequencing method to accurately map the HBV transcriptome showed an increased abundance of pre-genomic RNA under hypoxic conditions. Mapping the transcription start sites of BCP-RNAs identified a role for hypoxia to regulate pre-genomic RNA splicing that is dependent on m6A methylation. Bio-informatic analysis of published single cell RNA-seq of murine liver showed an increased expression of the RNA demethylase ALKBH5 in the peri-central low oxygen region. In vitro studies with a human hepatocyte derived HepG2-NTCP cell line showed increased ALKBH5 gene expression under hypoxic conditions and a concomitant reduction in m6A-modified HBV BCP-RNA and host RNAs. Silencing the demethylase reduced the level of BCP-RNAs and host gene (CA9, NDRG1, VEGFA, BNIP3, FUT11, GAP and P4HA1) transcripts and this was mediated via reduced HIF alpha expression. In summary, our study highlights a previously unrecognized role for ALKBH5 in orchestrating viral and cellular transcriptional responses to low oxygen. Oxygen levels influence HBV replication and hypoxia inducible factors (HIFs) activate HBV transcription. Long-read sequencing and mapping the HBV transcriptome showed an increased abundance of viral RNAs under hypoxic conditions that was dependent on N6-methyladenosine modifications. Investigating the oxygen-dependent expression of RNA demethylases identified ALKBH5 as a hypoxic activated gene and silencing its expression showed a key role in regulating HBV and host gene expression under hypoxic conditions.
引用
收藏
页数:22
相关论文
共 50 条
  • [31] Deregulation of N6-Methyladenosine RNA Modification and Its Erasers FTO/ALKBH5 among the Main Renal Cell Tumor Subtypes
    Guimaraes-Teixeira, Catarina
    Barros-Silva, Daniela
    Lobo, Joao
    Soares-Fernandes, Diana
    Constancio, Vera
    Leite-Silva, Pedro
    Silva-Santos, Rui
    Braga, Isaac
    Henrique, Rui
    Miranda-Goncalves, Vera
    Jeronimo, Carmen
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (10):
  • [32] N6-methyladenosine demethylase FTO regulates synaptic and cognitive impairment by destabilizing PTEN mRNA in hypoxic-ischemic neonatal rats
    Deng, Jianhui
    Liao, Yanling
    Chen, Jianghu
    Chen, Andi
    Wu, Shuyan
    Huang, Yongxin
    Qian, Haitao
    Gao, Fei
    Wu, Guixi
    Chen, Yisheng
    Chen, Xiaohui
    Zheng, Xiaochun
    CELL DEATH & DISEASE, 2023, 14 (12)
  • [33] The RNA N6-methyladenosine demethylase FTO regulates ATG5 to inhibit malignant progression of uveal melanoma
    Yang, Yating
    Zhong, Yusheng
    Chi, Cheng
    Lin, Xiacheng
    Zhu, Xuemei
    Deng, Xun
    Liang, Jianhong
    Cheng, Yong
    JOURNAL OF PROTEOMICS, 2024, 309
  • [34] N6-methyladenosine demethylase FTO regulates synaptic and cognitive impairment by destabilizing PTEN mRNA in hypoxic-ischemic neonatal rats
    Jianhui Deng
    Yanling Liao
    Jianghu Chen
    Andi Chen
    Shuyan Wu
    Yongxin Huang
    Haitao Qian
    Fei Gao
    Guixi Wu
    Yisheng Chen
    Xiaohui Chen
    Xiaochun Zheng
    Cell Death & Disease, 14
  • [35] N6-methyladenosine ALKBH5 promotes non-small cell lung cancer progress by regulating TIMP3 stability
    Zhu, Zhiyuan
    Qian, Qi
    Zhao, Xia
    Ma, Liang
    Chen, Ping
    GENE, 2020, 731
  • [36] The role of RNA m6A demethylase ALKBH5 in the mechanisms of fibrosis
    Liao, Ziwei
    Wang, Jing
    Xu, Mengrou
    Li, Xiaoyan
    Xu, Hongming
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
  • [37] The functional role of m6A demethylase ALKBH5 in cardiomyocyte hypertrophy
    Meng, Chen
    Su, Haibi
    Shu, Meiling
    Shen, Feng
    Lu, Yijie
    Wu, Shishi
    Su, Zhenghua
    Yu, Mengyao
    Yang, Di
    CELL DEATH & DISEASE, 2024, 15 (09):
  • [38] Transcriptome-wide N6-methyladenosine analysis
    Hannah Stower
    Nature Reviews Genetics, 2012, 13 (7) : 452 - 452
  • [39] Discovery of maleimide derivatives as m6A demethylase ALKBH5 inhibitors
    Liang, Luxia
    Fei, Wenlong
    Wang, Yingzhe
    Zhang, Ze
    You, Qidong
    Guo, Xiaoke
    BIOORGANIC & MEDICINAL CHEMISTRY, 2025, 120
  • [40] RNA N6-METHYLADENOSINE ERASER ALKBH5 DRIVES STEMNESS AND CHEMORESISTANCE OF COLORECTAL CANCER THROUGH A M6A-FAM84A-B-CATENIN AXIS
    Zhou, Heming
    Wong, Chi Chun
    Chen, Huarong
    Cheung, Henley
    Liu, Weixin
    Liang, Cong
    Yu, Jun
    GASTROENTEROLOGY, 2024, 166 (05) : S187 - S187